X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (34) 34
female (29) 29
male (27) 27
adult (25) 25
middle aged (22) 22
urology & nephrology (22) 22
index medicus (18) 18
hypertension (15) 15
autosomal dominant polycystic kidney disease (14) 14
polycystic kidney, autosomal dominant - physiopathology (14) 14
disease progression (12) 12
adolescent (10) 10
glomerular filtration rate (10) 10
kidney - pathology (10) 10
article (9) 9
polycystic kidney, autosomal dominant - complications (9) 9
kidney - physiopathology (8) 8
angiotensin-converting enzyme inhibitors - therapeutic use (7) 7
hypertension - drug therapy (7) 7
polycystic kidney, autosomal dominant - pathology (7) 7
young adult (7) 7
blood pressure (6) 6
hypertension - etiology (6) 6
polycystic kidney disease (6) 6
polycystic kidney, autosomal dominant - genetics (6) 6
progression (6) 6
prospective studies (6) 6
risk factors (6) 6
treatment outcome (6) 6
antihypertensive agents - therapeutic use (5) 5
blood pressure - drug effects (5) 5
end-stage renal disease (5) 5
kidney diseases (5) 5
longitudinal studies (5) 5
medicine, general & internal (5) 5
polycystic kidney, autosomal dominant - diagnosis (5) 5
polycystic kidney, autosomal dominant - drug therapy (5) 5
total kidney volume (5) 5
abridged index medicus (4) 4
adpkd (4) 4
analysis (4) 4
cardiovascular-disease (4) 4
care and treatment (4) 4
child (4) 4
chronic kidney disease (4) 4
enalapril - therapeutic use (4) 4
endothelial dysfunction (4) 4
failure (4) 4
proteinuria (4) 4
renal-disease (4) 4
risk (4) 4
stage renal-disease (4) 4
time factors (4) 4
transplantation (4) 4
volume progression (4) 4
aged (3) 3
aldosterone (3) 3
angiotensin (3) 3
angiotensin-ii (3) 3
blood-pressure (3) 3
blood-pressure control (3) 3
converting enzyme-inhibition (3) 3
creatinine - blood (3) 3
drug therapy, combination (3) 3
excretion (3) 3
glomerular filtration rate - drug effects (3) 3
health aspects (3) 3
kidney - diagnostic imaging (3) 3
kidney - drug effects (3) 3
kidney failure, chronic - prevention & control (3) 3
kidney volume (3) 3
magnetic-resonance measurements (3) 3
mutation (3) 3
organ size (3) 3
oxidative stress (3) 3
phenotype (3) 3
polycystic kidney, autosomal dominant - metabolism (3) 3
prognosis (3) 3
renin (3) 3
acute interstitial nephritis (2) 2
age factors (2) 2
albumin (2) 2
amlodipine - therapeutic use (2) 2
anemia (2) 2
angiotensin ii type 1 receptor blockers - therapeutic use (2) 2
angiotensin-aldosterone system (2) 2
angiotensin-converting enzyme inhibitors (2) 2
autosomal-dominant polycystic kidney disease (2) 2
benzimidazoles - therapeutic use (2) 2
benzoates - therapeutic use (2) 2
child, preschool (2) 2
children (2) 2
chronic kidney failure (2) 2
chronic-renal-failure (2) 2
ckd (2) 2
clinical research (2) 2
complications and side effects (2) 2
creatinine (2) 2
creatinine - metabolism (2) 2
cysts (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 12/2014, Volume 371, Issue 24, pp. 2255 - 2266
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2014, Volume 371, Issue 24, pp. 2267 - 2276
This trial tested single versus dual inhibition of the renin–angiotensin–aldosterone system in ADPKD. ACE-inhibitor monotherapy controlled blood pressure in... 
RECEPTOR BLOCKER | MEDICINE, GENERAL & INTERNAL | RENIN | RAMIPRIL | COMBINATION THERAPY | ACE-INHIBITOR | BLOOD-PRESSURE CONTROL | PROTEINURIA | PROGRESSION | ALDOSTERONE SYSTEM | CONVERTING-ENZYME | Benzoates - therapeutic use | Renal Insufficiency, Chronic - etiology | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Middle Aged | Hypertension - drug therapy | Male | Aldosterone - urine | Hypertension - etiology | Renal Insufficiency, Chronic - drug therapy | Young Adult | Glomerular Filtration Rate - drug effects | Lisinopril - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Adult | Female | Blood Pressure - drug effects | Drug Therapy, Combination | Polycystic Kidney, Autosomal Dominant - drug therapy | Benzimidazoles - therapeutic use | Albuminuria - etiology | Double-Blind Method | Disease Progression | Kidney Failure, Chronic - prevention & control | Adolescent | Polycystic Kidney, Autosomal Dominant - physiopathology | Polycystic Kidney, Autosomal Dominant - complications | Treatment outcome | Care and treatment | Lisinopril | Analysis | Dosage and administration | Polycystic kidney disease | Telmisartan | Hypertension | End-stage renal disease | Excretion | Inhibitor drugs | Kidneys | Polycystic kidney | Diabetes mellitus | Albumin | Aldosterone | Glomerular filtration rate | Quality of life | Hyperkalemia | Renin | Pain | Angiotensin | Blood pressure | Kidney diseases | Drug therapy | Angiotensin II
Journal Article
American Journal of Kidney Diseases, ISSN 0272-6386, 06/2018, Volume 71, Issue 6, pp. 913 - 913
Journal Article
American Journal of Kidney Diseases, ISSN 0272-6386, 05/2018, Volume 71, Issue 5, pp. 666 - 676
Journal Article
Current hypertension reviews, 02/2013, Volume 9, Issue 1, p. 32
Autosomal dominant polycystic kidney disease (ADPKD) is the most common potentially lethal hereditary disease. The hall mark of the disease is the development... 
Oxidative Stress | Humans | Endothelium, Vascular - physiopathology | Neovascularization, Pathologic - physiopathology | Polycystic Kidney, Autosomal Dominant - physiopathology | Kidney - physiopathology
Journal Article
Kidney Medicine, ISSN 2590-0595, 10/2019
Journal Article
Journal Article
Current Hypertension Reviews, ISSN 1573-4021, 2017, Volume 13, Issue 2, pp. 109 - 120
Journal Article